microbiology

New phenotypic methods can help identify the best antibiotic to treat sepsis, UTIs, and other bacterial infections.

In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.

Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.

Gut microbes can protect or sensitize each other to drugs, even to non-antibiotics.

In a mix of innovation and accident, researchers developed a new antibiotic that has broad efficacy across Gram-positive bacteria.

Scientists developed an unprecedented chemical tool to visualize sphingomyelin and sphingomyelinase activity during a chlamydia infection.

Organ-on-a-chip technology can replicate the cervix microenvironment in bacterial vaginosis.

Bacteria can invade colorectal cancer tumors, leading to worse disease outcomes. Oxygen — or lack thereof — plays a vital role in this interaction.

A new model predicts how well maternal vaccines protect babies from Group B Streptococcus, propelling much needed shots through late-stage clinical trials.

Biofilms render most antibiotics ineffective, but ultrasound may be the key to clearing these chronic infections.